111
Views
7
CrossRef citations to date
0
Altmetric
Original Scientific Papers

15-Year lipid profile effects on cardiovascular events adjusted for cardiovascular risk factors: a cohort study from Middle-East

, , , , , , ORCID Icon, & show all
Pages 194-199 | Received 09 Oct 2019, Accepted 10 Jan 2020, Published online: 05 Feb 2020

References

  • Goldberg RJ, Glatfelter K, Burbank-Schmidt E, et al. Trends in community mortality due to coronary heart disease. Am Heart J. 2006;151:501–507.
  • Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210.
  • Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369:1336–1343.
  • Saadat S, Yousefifard M, Asady H, et al. The most important causes of death in Iranian population; a retrospective cohort study. Emergency. 2015;3:16–21.
  • Borhanuddin B, Mohd Nawi A, Shah SA, et al. 10-year cardiovascular disease risk estimation based on lipid profile-based and BMI-based Framingham risk scores across multiple sociodemographic characteristics: the Malaysian cohort project. Sci World J. 2018;2018. Article ID 2979206.
  • D’Agostino RB Sr, Pencina MJ, Massaro JM, et al. Cardiovascular disease risk assessment: insights from Framingham. Global Heart. 2013;8:11–23.
  • Conroy R, Pyörälä K, Fitzgerald Ae SS, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.
  • Reid RJ, Anderson ML, Fishman PA, et al. Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study. BMC Health Serv Res. 2015;15:281.
  • Muntner P, DeSalvo KB, Wildman RP, et al. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol. 2006;163:913–920.
  • Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
  • Poss J, Custodis F, Werner C, et al. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Design. 2011;17:861–870.
  • Sadeghi M, Talaei M, Oveisgharan S, et al. The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: the Isfahan Cohort Study. Adv Biomed Res. 2014;3:242.
  • Shlomo M, Kenneth S, Larsen P, et al. Williams textbook of endocrinology. Philadelphia (PA): Elsevier Saunders; 2011.
  • Rabani S, Sardarinia M, Akbarpour S, et al. 12-year trends in cardiovascular risk factors (2002–2005 through 2011–2014) in patients with cardiovascular diseases: Tehran lipid and glucose study. PLoS One. 2018;13:e0195543.
  • Rosolova H, Nussbaumerova B, Mayer O Jr, et al. Success and failure of cardiovascular disease prevention in Czech republic over the past 30 years. Czech part of the EUROASPIRE I-IV surveys. Physiol Res. 2017;66:S77.
  • Nordstrom BL, Collins JM, Donaldson R, et al. Treatment patterns and lipid levels among patients with high-risk atherosclerotic CVD in the UK. Br J Cardiol. 2015;22:147–154.
  • Danese MD, Gleeson M, Kutikova L, et al. Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. 2017;7:e013851.
  • Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952.
  • Spillmann F, Schultheiss H-P, Tschope C, et al. High-density lipoprotein-raising strategies: update 2010. Curr Pharm Des. 2010;16:1517–1530.
  • Hausenloy DJ, Yellon DM. Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels. Curr Opin Cardiol. 2009;24:473–482.
  • Gotto AM. Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation. 2001;103:2213–2218.
  • Windler E, Schöffauer M, Zyriax B-C. The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease. Diabet Vasc Dis Res. 2007;4:136–142.
  • Cremer P, Nagel D, Mann H, et al. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis. 1997;129:221–230.
  • Shai I, Rimm EB, Hankinson SE, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation. 2004;110:2824–2830.
  • Zyriax BC, Boeing H, Windler E. Nutrition is a powerful independent risk factor for coronary heart disease in women–The CORA study: a population-based case-control study. Eur J Clin Nutr. 2005;59:1201–1207.
  • Poss J, Custodis F, Werner C, et al. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des. 2011;17:861–870.
  • Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019;41:111–188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.